BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Europe

Nordic Bioscience and Roche Launch Elecsys PRO-C3 Test to Advance Liver Fibrosis Assessment on cobas Analyzers

Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used w...

May 09, 2025 | News

India to Gain Faster, Affordable Access to CAR T Therapy as NKure Therapeutics Partners with CRISPR Therapeutics

CTX112™ is an off-the-shelf investigational therapy, offering the potential for faster patient access compared to current CAR T treatments....

May 08, 2025 | News

AGC Biologics Partners with South Korea’s Novelty Nobility to Advance Bispecific Antibody Program Across Europe and Asia

Global CDMO supports South Korean company on a multiphase project at its Copenhagen and Chiba sites AGC Biologics, your friendly CDMO expert, an...

May 06, 2025 | News

Genmab to Submit sBLA for Epcoritamab-R2 Combination in Relapsed/Refractory Follicular Lymphoma Following Positive Phase 3 Data

--Genmab A/S (Nasdaq: GMAB) announced its intention to submit in the first half of 2025 a supplemental Biologics License Application (sBLA) to t...

May 05, 2025 | Regulatory

Aptamer Group and University of Glasgow Partner to Advance Optimer-Based Vaccine Adjuvants for Swine Health

Aptamer Group plc (AIM: APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, has ente...

May 01, 2025 | News

Henlius Licenses Ipilimumab Biosimilar HLX13 to Sandoz in $301M Global Deal

Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations Henlius to receive $...

April 30, 2025 | News

Eppendorf Enhances Automated Liquid Handling Efficiency With New epMotion® 4-Channel Tools

Eppendorf is expanding its product range in the field of automated liquid handling with the introduction of three new epMotion® 4-channel dispensing to...

April 29, 2025 | News

Merck to Acquire SpringWorks Therapeutics for $3.9 Billion, Strengthening Rare Tumor Leadership

Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $3.9 bill...

April 28, 2025 | News

Suvoda and Greenphire Merge to Create Unified Platform for Streamlining Clinical Trials

Suvoda, a global clinical trial technology company specializing in randomization and trial supply management, consent, and patient outcomes data collection...

April 25, 2025 | News

Beckman Coulter Launches OptiMATE Gradient Maker to Speed Up Ultracentrifugation Workflows

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of the OptiMATE Gradient...

April 24, 2025 | News

Onward Therapeutics Receives EMA Green Light for Phase 1 Trial of Allogeneic NK Cell Therapy in Relapsed DLBCL

Onward Therapeutics SA, a biotechnology company dedicated to advancing innovative cancer immunotherapies, announced that its subsidiary, Emercell SAS, has ...

April 23, 2025 | News

Eisai and Biogen’s Leqembi® Secures First-of-Its-Kind EU Authorization for Early Alzheimer’s

Eisai Co., Ltd. and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (Aβ) monoclonal antibody Leqembi® (...

April 21, 2025 | News

Brain Navi Initiates IPO Counseling with First Securities to Accelerate Growth in AI-Driven Surgical Robotics

Brain Navi Biotechnology Co., Ltd. ("Brain Navi") has officially begun IPO counseling with First Securities Inc., marking a strategic step toward acce...

April 18, 2025 | News

Saudi Arabia and France Sign Strategic Agreements to Boost Collaboration in Biotech and Digital Health

Saudi Arabia and France have signed strategic agreements focusing on biotechnology and digital health. These partnerships aim to accelerate innovation, imp...

April 17, 2025 | News

Stay Connected